92490 ⎘
Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
Sub-classes:Serotonin 5-HT2A, 5-HT2B, and 5-HT2C Receptor Inverse Agonists
#2LIPID NANOMATERIALS AND USES THEREOF
#3COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME
#4PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME
#5Organic photodetector and electronic device including the same
#6SMALL MOLECULE INHIBITORS OF Id PROTEINS
#7Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component
#8INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1
#9Benzylated triaminononane and uses thereof
#10Compounds for treatment of cardiac arrhythmias and heart failure
#11Inhibitors of kidney-type glutaminase, GLS-1
#12Production of tri-methyl benzene derivatives
#13Compositions and methods for treating diseases and conditions
#14Organic electroluminescent device
#15Organic electroluminescent device
#16Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer
#17Organic electroluminescent device
#18Compositions and methods for treating diseases and conditions
#19Inhibitors of kidney-type glutaminase, GLS-1
#20Tertiary amines for use in the treatment of cardiac disorders
#21Organic light-emitting device
#22Organic electroluminescent device
#23Organic electroluminescent device
#24Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#25Inhibitors targeting drug-resistant influenza A
#26Tertiary amines for use in the treatment of cardiac disorders
#27Hardeners for epoxy resin coatings
#28Compounds for treating ophthalmic diseases and disorders
#29Selective sigma-1 receptor ligands
#30Charge transport compositions and electronic devices made with such compositions
#31Process for the preparation of tapentadol and intermediates thereof
#32Charge transport compositions and electronic devices made with such compositions
#33Process for preparing toluenediamine by hydrogenation of dinitrotoluene
#34Charge transport compositions and electronic devices made with such compositions
#35Chain extenders
#36Charge transport compositions and electronic devices made with such compositions
#37SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#38Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
#39Sigma-1 receptor ligands and methods of use
#40Compounds for treating ophthalmic diseases and disorders
#41Alkylated 4-Aminobenzyl-4-Aminocyclohexane
#42Method for producing an optically active tetrahydroquinoline
#43CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS
#445-HT2C Receptor Agonists as Anorectic Agents
#45Electronic devices made with electron transport and/or anti-quenching layers
#46Charge transport compositions and electronic devices made with such compositions
#47Chain extenders
#48ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS
#49POLYAMINES USEFUL AS ANTI-PARASITIC AND ANTI-CANCER THERAPEUTICS AND AS LYSINE-SPECIFIC DEMETHYLASE INHIBITORS
#50Charge transport compositions and electronic devices made with such compositions
#51Benzimidazolyl derivatives
#52Optically active transition metal-diamine compound and process for producing optically active alcohol with the same
#53Method for producing an optically active tetrahydroquinoline
#54Charge transport compositions and electronic devices made with such compounds
#55Methods and compositions comprising diamines as new anti-tubercular therapeutics